GIP
BMY.RT

Granite Investment Partners’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Granite Investment Partners’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,958
Closed -$3K – 299
2020
Q4 		$3K Hold
3,958
– – ﹤0.01% 275
2020
Q3 		$9K Hold
3,958
– – ﹤0.01% 269
2020
Q2 		$14K Hold
3,958
– – ﹤0.01% 265
2020
Q1 		$15K Sell
3,958
-350
-8% -$1.15K ﹤0.01% 265
2019
Q4 		$13K Buy
+4,308
New +$11.2K ﹤0.01% 290

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Granite Investment Partners's BMY.RT Position: Q1 2021 in Review

Granite Investment Partners sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 3,958 shares — an estimated $3K sold.

Granite Investment Partners first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $15K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Granite Investment Partners reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Granite Investment Partners sold 3,958 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $3K.
  • Granite Investment Partners first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Granite Investment Partners's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $15K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Granite Investment Partners's 13F filing for Q1 2021, filed 13 May 2021.